Raiffeisen Bank International »

Beam Therapeutics shares owned by Raiffeisen Bank International

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Raiffeisen Bank International from 13F filings

Historical chart of Raiffeisen Bank International investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Raiffeisen Bank International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Raiffeisen Bank International

Quarter filed Position value Share count Share price at filing
2026-03-31 $986k 45k 21.90

More positions owned by Raiffeisen Bank International

Nvidia Corp Common Stock (NVDA)
Alphabet Common Stock (GOOGL)
Apple Common Stock (AAPL)
Broadcom Common Stock (AVGO)
Amazoncom Common Stock (AMZN)
Applied Materials Common Stock (AMAT)
Eli Lilly & Co Common Stock (LLY)
Lam Research Corp Common Stock (LRCX)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Jpmorgan Chase & Co Common Stock (JPM)
Cisco Systems Common Stock (CSCO)
Abbvie Common Stock (ABBV)
Visa Common Stock (V)
Quanta Services Common Stock (PWR)
Advanced Micro Devices Common Stock (AMD)

View all positions for Raiffeisen Bank International

Top funds holding Beam Therapeutics

FMR
ARK Investment Management
Farallon Capital Management
Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Arch Venture Corp
Vanguard Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Kynam Capital Management
Geode Capital Management
Dimensional Fund Advisors
Ubs Global Asset Management Americas

View all funds holding Beam Therapeutics